Request Trial
24 February 2026NewsCareersSarah Speight

Wiggin’s new litigation partner deepens ‘technically complex’ offer

The New York hire brings broad litigation and transactional experience, including advising clients on artificial intelligence, biotech, pharma and chemical matters.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Careers
Cooley Asia transactions duo make rival firm move
23 June 2026   The pair bring a strong track record advising life sciences companies on licensing, collaboration and commercialisation agreements, with a particular focus on cross-border biotech transactions.
Careers
Ex-Simmons head of IP joins Carpmaels & Ransford
15 June 2026   Highly experienced partner is the second big name to join the firm this year, expanding its Engineering & Tech practice and beefing up its IP disputes work.
Careers
MoFo bags IP trial duo with 50 years’ combined experience
11 June 2026   The opportunity to grow a “powerhouse IP litigation practice in the heart of New York” was behind the lateral move of highly experienced litigators to Morrison Foerster.


Editor's picks

Hikma v Amarin: Six takeaways from the pivotal ruling
Americas
Hikma v Amarin: Six takeaways from the pivotal ruling
9 June 2026

Editor's picks

Americas
Hikma v Amarin: Six takeaways from the pivotal ruling
9 June 2026
Americas
UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
14 May 2026
Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026
Americas
Penile implant maker’s $17m trade secret award unravels
20 April 2026
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026
Europe
European patent offices raise fees
2 April 2026

More features

Novartis and Eli Lilly sign separate $1.9bn novel drug deals
Novo secures website blocking to tackle fake weight-loss drugs
GLP-1 patents and Africa: The COVID-19 lessons we still have not learned
Cooley Asia transactions duo make rival firm move
Insilico lands potential $2.5bn AI biotech partnership
‘Blatant imitation’: Indian court blocks copycat pharma branding
UPC hands Occlutech second win against Chinese medtech company in a month
US life sciences damages averaged $33.5m between 2019-2025